Comparing the Combined Effect of Stability Exercises with Emphasis on Pelvic Floor Muscles and Interference Current on Improving the symptoms of Women with Stress Urinary Incontinence

Not Applicable

Recruiting

Conditions: Stress urinary inconvenience.
Stress incontinence (female) (male)
N39.3

Registration Number: IRCT20161221031506N9

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 22

Inclusion Criteria

Have experienced stress urinary incontinence at least twice a week for two weeks. Stress urinary incontinence was confirmed by urodynamic tests and clinical examination.
Mild and moderate stress urinary incontinence
No history of taking anticholinergic drugs and other drugs during physiotherapy period.

Exclusion Criteria

smoking
Known types of neuropathy
Virginity
Pregnancy and lactation
History of pelvic surgery in the past year
History of reconstructive surgery in the genitourinary system
Having a urinary tract infection
Chronic asthma and cough (more than three months)
Having perceptual problems and mental illness based on a doctor's examination
History of genitourinary neoplasia
History of abnormalities in the genitourinary system
Having any type of urinary incontinence other than pure stress urinary incontinence
Severe stress urinary incontinence
Severe prolapse
Urethral hyper mobility
Intrinsic sphincter dysfunction
Severe neuromuscular disorders that compromise exercise performance

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean maximum intravaginal pressure. Timepoint: Immediately after allocation into , 4 and 8 weeks after starting treatment. Method of measurement: Pressure biofeedback.;Quality of life. Timepoint: Immediately after allocation into , 4 and 8 weeks after starting treatment. Method of measurement: ???? ???????? I_QOL.;ICIQ_UI SF questionnaire score. Timepoint: Immediately after allocation into , 4 and 8 weeks after starting treatment. Method of measurement: ICIQ_UI SF questionnaire.;Duration of maintenance of maximum intravaginal pressure. Timepoint: Immediately after allocation into , 4 and 8 weeks after starting treatment. Method of measurement: Pressure biofeedback.;Frequent urinary incontinence for a week. Timepoint: Immediately after allocation into , 4 and 8 weeks after starting treatment. Method of measurement: With bladder diary.

Secondary Outcome Measures